Source: Dermatology Times
Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm Volbella XC for infraorbital hollow improvement for patients over the age of 21.
Source: Dermatology Times
Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm Volbella XC for infraorbital hollow improvement for patients over the age of 21.